CLOs on the Move

The Tech Group Subsidiary of West Pharmaceutica

www.techgroup.com

 
The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. is based in Scottsdale, AZ. You can find more information on The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. at www.techgroup.com
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

BDC Advisors

BDC Advisors is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InterGanics

InterGanics is a global solution-driven company that supports ingredients and finish products manufacturers to design an environmentally safe, socially responsible and economically sustainable sourcing strategy around Organic, Non-GMO and Specialty products.

Neurology Partners

Neurology Partners is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Physical Rehabilitation Network

Physical Rehabilitation Network (PRN) was founded in 1991 to assist physical therapists in developing and operating their own practice without carrying the burden of business administration and back office functions. In this capacity our partners can focus on what they do best - providing excellence in patient care! PRN has a fierce commitment to our therapist partners with proven revenue cycle management, personalized human resources, regional business development and contract opportunities. PRN is the most prominent network of independently operated physical & hand rehabilitation centers in the western United States. After starting out in southern California with one practice, PRN presently serves over 120 centers in nine states.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.